← Back to Analyst Consensus 
TWST Buy
Twist Bioscience Corp
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 5 reiterations from 6 firms
Next Earnings
Nov 13, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 12, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 8, 2026 | Jefferies | initiate | — → Hold | — | 52% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Oct 1, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Sep 29, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Sep 18, 2026 | BWS Financial | maintain | Sell → Sell | — | 60% |
| Sep 17, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Sep 9, 2026 | BWS Financial | initiate | — → Sell | — | 60% |
| Sep 9, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Aug 5, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jul 14, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 6, 2026 | Evercore ISI Group | downgrade | Outperform → In-Line | — | 58% |
| Jun 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jun 15, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jun 15, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jun 11, 2026 | Piper Sandler | initiate | Overweight → Overweight | — | 54% |
| May 5, 2026 | Leerink Partners | upgrade | Market Perform → Outperform | — | 51% |
| May 5, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 5, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 5, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Apr 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 30, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Feb 3, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $52 | 58% |
| Feb 3, 2026 | Barclays | maintain | Overweight → Overweight | $50 | 53% |
| Jan 26, 2026 | Guggenheim | maintain | Buy → Buy | $50 | 52% |
| Jan 8, 2026 | TD Cowen | maintain | Buy → Buy | $43 | 54% |
| Dec 15, 2025 | Barclays | maintain | Overweight → Overweight | $39 | 53% |
| Nov 17, 2025 | Barclays | maintain | Overweight → Overweight | $37 | 53% |
| Nov 4, 2025 | Stephens & Co. | initiate | — → Overweight | $41 | 54% |
| Oct 7, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $42 | 58% |
| Oct 2, 2025 | Barclays | maintain | Overweight → Overweight | $40 | 53% |
| May 6, 2025 | Goldman Sachs | maintain | Buy → Buy | $48 | 54% |
| May 6, 2025 | Guggenheim | reiterate | Buy → Buy | $50 | 52% |
| May 6, 2025 | Baird | maintain | Outperform → Outperform | $44 | 55% |
| May 6, 2025 | JP Morgan | maintain | Underweight → Underweight | $33 | 55% |
| Apr 10, 2025 | Barclays | maintain | Overweight → Overweight | $45 | 53% |
| Feb 4, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $62 | 55% |
| Feb 4, 2025 | JP Morgan | maintain | Underweight → Underweight | $40 | 55% |
| Feb 4, 2025 | Baird | maintain | Outperform → Outperform | $54 | 55% |
| Dec 13, 2024 | Wolfe Research | initiate | — → Outperform | $60 | 54% |
| Nov 26, 2024 | TD Cowen | reiterate | Buy → Buy | $58 | 54% |
| Nov 19, 2024 | Barclays | maintain | Overweight → Overweight | $52 | 53% |
| Nov 19, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $54 | 55% |
| Nov 19, 2024 | Baird | maintain | Outperform → Outperform | $48 | 55% |
| Oct 17, 2024 | Leerink Partners | maintain | Market Perform → Market Perform | $48 | 51% |
| Oct 1, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $56 | 58% |
Price Target Trend
Jul 26, 2026 Oct 27, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days